Contact

Partner with us.

If metabolic state is a variable in drug response, it changes how you design trials, select patients, and interpret failures. We'd like to talk about what that means for your pipeline.

Get in touch

We are particularly interested in conversations about

  • Strategic partnerships in CNS, oncology, and metabolic disease

  • Co-development and licensing opportunities

  • Metabolic stratification of existing clinical trial datasets

  • Scientific collaboration on metabolic state therapeutics

  • Investment in platform-stage biopharmaceutical companies

Research Inquiries

For inquiries related to the foundational research in Metabolic State Medicine, please visit the research network at metabolicstatemedicine.org.